VerifyMe (NASDAQ: VRME) gets June 10, 2026 deadline to fix Nasdaq $1 bid issue
Rhea-AI Filing Summary
VerifyMe, Inc. disclosed that it received a notice from Nasdaq stating its common stock no longer meets the exchange’s minimum bid price requirement of $1 per share, because the closing bid has been below that level for 30 consecutive business days.
Under Nasdaq Listing Rule 5810(c)(3)(A), VerifyMe has a 180-day grace period, until June 10, 2026, to regain compliance by achieving a closing bid price of at least $1 per share for a minimum of 10 consecutive business days. If the company does not regain compliance by that date, it may qualify for an additional 180-day period if it meets other Nasdaq Capital Market listing standards and notifies Nasdaq of its intent to cure the deficiency.
If VerifyMe ultimately fails to satisfy the continued listing standards, its common stock could be delisted from Nasdaq, although the company would have the right to appeal a delisting determination. The notice does not immediately affect the stock’s current Nasdaq listing, and VerifyMe states it will monitor its share price and consider available options if the bid remains below $1.
Positive
- None.
Negative
- Nasdaq bid-price deficiency: VerifyMe’s common stock no longer meets Nasdaq’s $1 minimum bid requirement after 30 consecutive business days below that level, introducing delisting risk if not cured.
Insights
VerifyMe faces a Nasdaq minimum bid-price deficiency with a defined cure window.
The disclosure explains that VerifyMe, Inc. has fallen out of compliance with Nasdaq Listing Rule 5550(a)(2) because its common stock’s closing bid price stayed below $1 for 30 consecutive business days. This triggers a formal deficiency notice but not an immediate delisting. The company remains traded on the Nasdaq Capital Market while it works within the exchange’s rules-based timeline.
Nasdaq has granted a 180-day compliance period, through June 10, 2026, during which VerifyMe can regain compliance by maintaining a closing bid of at least $1 for 10 consecutive business days. If that does not occur, the company may seek a second 180-day period, provided it meets other initial listing standards for the Nasdaq Capital Market and informs Nasdaq of its intention to cure the bid-price issue. Failure to resolve the deficiency could lead to a delisting notice, which VerifyMe would be entitled to appeal to a Nasdaq hearings panel.
The company notes that the notification currently has no immediate effect on trading and states it intends to monitor its stock price and consider available options if the bid remains under $1. Any longer-term outcome will depend on future share-price performance and, if needed, specific actions the company may choose to take within the Nasdaq framework.
8-K Event Classification
FAQ
Why did VerifyMe (VRME) receive a notice from Nasdaq?
How long does VerifyMe (VRME) have to regain Nasdaq bid-price compliance?
Can VerifyMe (VRME) get more time if it does not meet the $1 minimum bid by June 10, 2026?
What happens if VerifyMe (VRME) ultimately fails to meet Nasdaq’s continued listing standards?
Does the Nasdaq deficiency notice immediately affect VerifyMe’s (VRME) listing or trading?
What steps does VerifyMe (VRME) mention in response to the Nasdaq notice?